Find your path to Vikas
458 people in our graph share verified history with Vikas — schools, employers, funds. One of them is your warm intro.
Paul JennyunlockedVikas: together at University of Washington (2013)
×5Vikas: together at Massachusetts General Hospital
×3Vikas: together at Massachusetts General Hospital, Harvard Medical School
Vikas: together at Fred Hutch
About
Vikas Goel is Head of Biology at Zafrens, with over 14 years of experience in biotech and pharma advancing small-molecule programs from hit identification through IND and clinical translation. He contributed to the FDA-approved therapy repotrectinib (Augtyro, 2023) and to five clinical-stage programs spanning oncology, immunology, and cardiometabolic disease. His work covers target identification and validation, high-throughput and platform biology, translational biology, and team leadership, including originating the MNK1/2 T cell biology program at eFFECTOR.
Executive at Zafrens
Intro paths
→
In turn, Vikas can intro founders to Zafrens's investors below.
Zafrens's investors · 9
Acequia Capital (AceCap)Seattle · $100K – $5M checks · since 2021BlueYard CapitalBerlin · $500K – $5M checks · since 2021FoundersX VenturesSilicon Valley · since 2021Global BrainTokyo · $100K – $184M checks · since 2021HAWKTAILSan Francisco · since 2021Iaso VenturesCambridge · since 2021imec.xpandLeuven · $270K – $5.4M checks · since 2021Prime Movers LabJackson · $2M – $30M checks · since 2021Raptor GroupMiami Beach · since 2021
Co-founders at Zafrens
MN
Maina Ndungu
Experience
- ZafrensHead of Biologycurrent2023 — presentSan Diego, CA
- Turning Point TherapeuticsDirector of Cancer Biology and Translational Research2020 — 2023San Diego, CA
- Bristol Myers Squibb / Turning Point TherapeuticsDirector Biology2020 — 2023
- eFFECTOR Therapeutics, Inc.Principal Scientist2020San Diego, California, United States
- eFFECTOR Therapeutics, Inc.Senior Scientist2015 — 2019Greater San Diego Area
- eFFECTOR Therapeutics, Inc.Research scientist II2013 — 2015San Diego
- eFFECTOR TherapeuticsPrincipal Research Scientist2013 — 2020
- University of WashingtonResearch Scientist2013Seattle
- Fred Hutchinson Cancer Research CenterResearch Associate II2009 — 2013
- Burnham Institute of Medical ResearchStaff Scientist2008 — 2009
- Massachusetts General Hospital, Harvard Medical SchoolInstructor2005 — 2007
- Massachusetts General HospitalPostDoctoral Fellow2002 — 2005
- All India Institute of Medical SciencesSenior Research Associate1997 — 2000
- All India Institute of Medical SciencesJunior Research Associate1995 — 1997
- Honors and PrizesAll India Institute of Medical Sciences1995 — 2000
- University of DelhiJunior Research Associate1994 — 1995
Skills & more
EpigeneticsRegulatory AffairsBiopharmaceuticalsMelanoma ResearchGPCRsCandidate DevelopmentStructural BiologyMicrofluidicsPharmaceutical ChemistryOncology Clinical ResearchData-driven Decision MakingPharmaceutical process development
+12 more
Biology EducationClinical DevelopmentPharmacologyDeconvolutionFunctional GenomicsProduct Lifecycle ManagementRisk Management PlansMelanomaInvestigational New Drug Application (IND)Clinical Pathway SystemsTeam LeadershipLeadershipLanguages Hindi, Punjabi
From Vikas's professional profile.
Frequently asked questions
- Who is Vikas Goel?
- Vikas Goel is Head of Biology at Zafrens, with over 14 years of experience in biotech and pharma advancing small-molecule programs from hit identification through IND and clinical translation. He contributed to the FDA-approved therapy repotrectinib (Augtyro, 2023) and to five clinical-stage programs spanning oncology, immunology, and cardiometabolic disease. His work covers target identification and validation, high-throughput and platform biology, translational biology, and team leadership, including originating the MNK1/2 T cell biology program at eFFECTOR.
- Where did Vikas Goel go to school?
- Vikas Goel studied at All India Institute of Medical Sciences (Doctor of Philosophy (Ph.D.), Molecular Microbiology); Delhi University (Master of Philosophy (M.Phil.), Molecular Parasitology); Dept. of Zoology, University of Delhi (Master's degree, Cell and Molecular Biology).
Same school
Also attended All India Institute of Medical Sciences7
Shreeram AradhyeInvestor at Novartis Venture FundCherian DrFounder at Synapsica HealthcareGandharv GoyalFounder at Synapsica HealthcareDr Arbinder SingalHead, Preventive & Digital Health at FitterflyKishlay AnandCEO; Manager of Manager of Issuer at Akos MDUdayan GuhaExecutive Officer at NextCure
+ 1 more
Also attended Delhi University201
Sourabh Kumar GuptaAssociate - Corporate Development at Fireside Ventures Advisory LlpKritika KashyapEA at Fireside Ventures Advisory LlpRama KannanGeneral Partner Advisor at Beyond Capital VenturesAmrit RajPartner & Chief Marketing Officer at Jungle VenturesShunyam GuptaAnalyst, Asia at RTP GlobalAtul DhawanAudit & Strategy Mentor at SenseAI Ventures
+ 195 more
Shared employers
Also worked at Turning Point Therapeutics4
Also worked at University of Washington203
Mike FridgenVenture Partner at Madrona Venture GroupSid ShenaiVenture partner at Madrona and co-founder and CEO of Proof DiagnosticsPaul JennyBoard Chair at CincyTechJason PrestonInvestor at Alsop Louie PartnersElliot HershbergScientist, Writer, and Investor on a mission to accelerate The Century of BiologyLuke RigganAssociate at Amplify Partners
+ 197 more
Also worked at Fred Hutchinson Cancer Research Center17
Luke RigganAssociate at Amplify PartnersMichael KalosInvestor at 82VSNida ShekhaniDeputy COO & Chief Strategy Officer at Oncology VenturesMark FleischauerPartner at FusionX VenturesJoris VanderlochtChief Scientific Director at Bioqube VenturesBryan WhiteCIO at Sahsen Ventures
+ 11 more
Also worked at Massachusetts General Hospital, Harvard Medical School336
Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux CapitalZach CollinsPartner at Mission BiocapitalAlexi Nazem, MDGeneral Partner at AlleyCorp
+ 330 more